11,874 Images : Last Update : Jan 20, 2023

Primary Effusion Lymphoma : Treatment & Prognosis

prev
slide 9 of 12
next
No Image
HemePath_PEL6_resized.jpg

Close

Comments:
Treatment & Prognosis: Primary effusion lymphoma is an aggressive disease with poor prognosis. Despite therapy, median survival is < 6 months.. In cases where the tumor cells express CD38 and initial systemic therapies have failed, the use of daratumumab (anti-CD38 antibody) has produced tumor response and lowering of HHV8 levels.

Image courtesy of: Laura Brown, MD; used with permission.

prev
slide 9 of 12
next